DE69813216T2 - Oligosaccharidemischungen mit antithrombotischer wirkung - Google Patents

Oligosaccharidemischungen mit antithrombotischer wirkung Download PDF

Info

Publication number
DE69813216T2
DE69813216T2 DE69813216T DE69813216T DE69813216T2 DE 69813216 T2 DE69813216 T2 DE 69813216T2 DE 69813216 T DE69813216 T DE 69813216T DE 69813216 T DE69813216 T DE 69813216T DE 69813216 T2 DE69813216 T2 DE 69813216T2
Authority
DE
Germany
Prior art keywords
mixture
weight
content
sulphate
disaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69813216T
Other languages
English (en)
Other versions
DE69813216D1 (de
Inventor
Mons Lundqvist
Betton Johansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10813494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69813216(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharma AS filed Critical Leo Pharma AS
Application granted granted Critical
Publication of DE69813216D1 publication Critical patent/DE69813216D1/de
Publication of DE69813216T2 publication Critical patent/DE69813216T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DE69813216T 1997-06-03 1998-05-15 Oligosaccharidemischungen mit antithrombotischer wirkung Revoked DE69813216T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711443.3A GB9711443D0 (en) 1997-06-03 1997-06-03 Chemical suppositions
PCT/EP1998/003007 WO1998055514A1 (en) 1997-06-03 1998-05-15 Oligosaccharide mixtures having antithrombotic activity

Publications (2)

Publication Number Publication Date
DE69813216D1 DE69813216D1 (de) 2003-05-15
DE69813216T2 true DE69813216T2 (de) 2004-01-29

Family

ID=10813494

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69813216T Revoked DE69813216T2 (de) 1997-06-03 1998-05-15 Oligosaccharidemischungen mit antithrombotischer wirkung

Country Status (20)

Country Link
US (1) US6486137B1 (de)
EP (1) EP0986580B1 (de)
JP (1) JP2002502454A (de)
KR (1) KR20010013284A (de)
CN (1) CN1145643C (de)
AT (1) ATE236933T1 (de)
AU (1) AU740671B2 (de)
CA (1) CA2293587A1 (de)
CZ (1) CZ292622B6 (de)
DE (1) DE69813216T2 (de)
DK (1) DK0986580T3 (de)
ES (1) ES2193534T3 (de)
GB (1) GB9711443D0 (de)
HK (1) HK1028251A1 (de)
HU (1) HUP0002333A3 (de)
NZ (1) NZ501254A (de)
PL (1) PL337231A1 (de)
PT (1) PT986580E (de)
RU (1) RU2216548C2 (de)
WO (1) WO1998055514A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998014169A1 (en) 1996-09-30 1998-04-09 Brigham & Women's Hospital Methods and compounds for treatment of abnormal uterine bleeding
EP1423130A1 (de) * 2001-08-28 2004-06-02 Leo Pharma A/S Antithrombotische zusammensetzungen mit niedermolekularem heparin und niedermolekularem dermatan-sulfat
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
CN100345868C (zh) * 2003-04-18 2007-10-31 山东大学 一种低分子硫酸皮肤素及其制备方法
WO2005092931A1 (en) * 2004-03-26 2005-10-06 Taisho Pharmaceutical Co., Ltd. Preparation process of oligoglycosaminoglycan, and reducing end glucuronic acid type oligochondroitin sulfate and pharmaceutical composition comprising the same
US20050261241A1 (en) 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
CN102046781A (zh) * 2008-05-30 2011-05-04 动量制药公司 糖结构以及制造和使用此类结构的方法
ES2364683B1 (es) * 2009-12-29 2012-08-08 Bioibérica S.A. Disacáridos sulfatados para el tratamiento de enfermedades neurodegenerativas y/o neurovasculares.
WO2013006906A1 (en) * 2011-07-11 2013-01-17 Commonwealth Scientific And Industrial Research Organisation Dermatan sulphate, pharmaceutical compositions and process for producing same
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
DK2794665T3 (da) 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf
CN103160486A (zh) * 2013-04-02 2013-06-19 黑龙江迪龙制药有限公司 一种猪凝血酶的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230582B (it) * 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
IT1251182B (it) * 1991-08-28 1995-05-04 Opocrin Spa Oligosaccaridi di dermatan solfato, processo per la loro produzione e relative composizioni farmaceutiche.
IT1251183B (it) * 1991-08-28 1995-05-04 Opocrin Spa Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono.
US5922690A (en) * 1996-04-25 1999-07-13 Van Gorp; Cornelius L. Dermatan disulfate, an inhibitor of thrombin generation and activation

Also Published As

Publication number Publication date
EP0986580B1 (de) 2003-04-09
EP0986580A1 (de) 2000-03-22
CN1145643C (zh) 2004-04-14
CA2293587A1 (en) 1998-12-10
DE69813216D1 (de) 2003-05-15
CN1259143A (zh) 2000-07-05
PT986580E (pt) 2003-08-29
WO1998055514A1 (en) 1998-12-10
AU7914698A (en) 1998-12-21
ES2193534T3 (es) 2003-11-01
HUP0002333A2 (hu) 2000-12-28
KR20010013284A (ko) 2001-02-26
NZ501254A (en) 2001-12-21
GB9711443D0 (en) 1997-07-30
DK0986580T3 (da) 2003-08-04
HUP0002333A3 (en) 2002-01-28
AU740671B2 (en) 2001-11-08
ATE236933T1 (de) 2003-04-15
US6486137B1 (en) 2002-11-26
RU2216548C2 (ru) 2003-11-20
JP2002502454A (ja) 2002-01-22
CZ292622B6 (cs) 2003-11-12
CZ431699A3 (cs) 2000-04-12
HK1028251A1 (en) 2001-02-09
PL337231A1 (en) 2000-08-14

Similar Documents

Publication Publication Date Title
DE69813216T2 (de) Oligosaccharidemischungen mit antithrombotischer wirkung
IT1271057B (it) Polisaccaridi aventi un elevato contenuto di acido iduronico
ATE548393T1 (de) Mischungen von aus heparin hergestellten oligosacchariden, deren herstellung und diese enthaltenden pharmazeutischen zusammensetzungen
ES8206555A1 (es) Procedimiento de preparacion de mezclas de polisacaridos sulfatados.
ES2021905A6 (es) Procedimiento para la preparacion de fracciones de sulfato de dermatano.
CA2007616A1 (en) Heparinic derivatives and process for their preparation
ES2161615A1 (es) Composiciones de heparinas de muy bajo peso molecular.
TR199901334A2 (xx) Sa� muamelesi i�in maddeler ve bu maddelerin bile�imleri.
RU2000100374A (ru) Смеси олигосахаридов, обладающие антитромботической активностью
AU637143B2 (en) Sulphated glycosaminoglycuronan with antithrombotic activity
PL337356A1 (en) Highly transparent polymeric composition
ES8802470A1 (es) Un procedimiento para la preparacion de un nuevo agente antitrombosico a base de una mezcla de glicosaminoglicanos.
AU5833694A (en) Oligosaccharides having biological activity and preparation of same from glycosaminoglycans
Casu Structure, shape and function of glycosaminoglycans

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: LEO PHARMA A/S, BALLERUP, DK

8363 Opposition against the patent
8331 Complete revocation